Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

J.Y. Chang; S. Senan; M.A. Paul; R.J. Mehran; A.V. Louie; P. Balter; H.J.M. Groen; S.E. McRae; J. Widder; L. Feng; B.E.M. van den Borne; M.F. Munsell; C. Hurkmans; D.A. Berry; E. van Werkhoven; J.J. Kresl; A.M. Dingemans; O. Dawood; C.J.A. Haasbeek; L.S. Carpenter; K. de Jaeger; R. Komaki; B. Slotman; E.F. Smit; J.A. Roth

doi:https://doi.org/10.1016/S1470-2045(15)70168-3

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

J.Y. Chang, S. Senan, M.A. Paul, R.J. Mehran, A.V. Louie, P. Balter, H.J.M. Groen, S.E. McRae, J. Widder, L. Feng, B.E.M. van den Borne, M.F. Munsell, C. Hurkmans, D.A. Berry, E. van Werkhoven, J.J. Kresl, A.M. Dingemans, O. Dawood, C.J.A. Haasbeek, L.S. CarpenterK. de Jaeger, R. Komaki, B. Slotman, E.F. Smit, J.A. Roth

Research output: Contribution to journal › Article › Academic › peer-review

1108 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	630-637
Journal	lancet oncology
Volume	16
Issue number	6
DOIs	https://doi.org/10.1016/S1470-2045(15)70168-3
Publication status	Published - 2015

Access to Document

https://doi.org/10.1016/S1470-2045(15)70168-3

Cite this

Chang, J. Y., Senan, S., Paul, M. A., Mehran, R. J., Louie, A. V., Balter, P., Groen, H. J. M., McRae, S. E., Widder, J., Feng, L., van den Borne, B. E. M., Munsell, M. F., Hurkmans, C., Berry, D. A., van Werkhoven, E., Kresl, J. J., Dingemans, A. M., Dawood, O., Haasbeek, C. J. A., ... Roth, J. A. (2015). Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. lancet oncology, 16(6), 630-637. https://doi.org/10.1016/S1470-2045(15)70168-3

@article{f179bdccbb214268961998b99f1f4375,

title = "Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials",

author = "J.Y. Chang and S. Senan and M.A. Paul and R.J. Mehran and A.V. Louie and P. Balter and H.J.M. Groen and S.E. McRae and J. Widder and L. Feng and {van den Borne}, B.E.M. and M.F. Munsell and C. Hurkmans and D.A. Berry and {van Werkhoven}, E. and J.J. Kresl and A.M. Dingemans and O. Dawood and C.J.A. Haasbeek and L.S. Carpenter and {de Jaeger}, K. and R. Komaki and B. Slotman and E.F. Smit and J.A. Roth",

year = "2015",

doi = "https://doi.org/10.1016/S1470-2045(15)70168-3",

language = "Undefined/Unknown",

volume = "16",

pages = "630--637",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "6",

}

Chang, JY, Senan, S, Paul, MA, Mehran, RJ, Louie, AV, Balter, P, Groen, HJM, McRae, SE, Widder, J, Feng, L, van den Borne, BEM, Munsell, MF, Hurkmans, C, Berry, DA, van Werkhoven, E, Kresl, JJ, Dingemans, AM, Dawood, O, Haasbeek, CJA, Carpenter, LS, de Jaeger, K, Komaki, R, Slotman, B, Smit, EF & Roth, JA 2015, 'Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials', lancet oncology, vol. 16, no. 6, pp. 630-637. https://doi.org/10.1016/S1470-2045(15)70168-3

TY - JOUR

T1 - Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

AU - Chang, J.Y.

AU - Senan, S.

AU - Paul, M.A.

AU - Mehran, R.J.

AU - Louie, A.V.

AU - Balter, P.

AU - Groen, H.J.M.

AU - McRae, S.E.

AU - Widder, J.

AU - Feng, L.

AU - van den Borne, B.E.M.

AU - Munsell, M.F.

AU - Hurkmans, C.

AU - Berry, D.A.

AU - van Werkhoven, E.

AU - Kresl, J.J.

AU - Dingemans, A.M.

AU - Dawood, O.

AU - Haasbeek, C.J.A.

AU - Carpenter, L.S.

AU - de Jaeger, K.

AU - Komaki, R.

AU - Slotman, B.

AU - Smit, E.F.

AU - Roth, J.A.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1016/S1470-2045(15)70168-3

DO - https://doi.org/10.1016/S1470-2045(15)70168-3

M3 - Article

SN - 1470-2045

VL - 16

SP - 630

EP - 637

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 6

ER -